ABOUT CANNOVATION

Cannovation is a U.S. based global clinical research organization (CRO) consulting firm that offers full-service preclinical/clinical research and commercialization services.

Cannovation is the first to partner with biopharmaceutical companies, universities, centers of excellence, and government agencies to bring innovative prescription and non-prescription therapeutics to market.

Cannovation specializes in all therapeutics including non-traditional cannabis and psychedelic based drugs and nutraceuticals.

Traditional CRO Services

Preclinical/clinical research (Phases 1-4)
All therapeutic classes (i.e. Oncology, CNS, Immunology, Women's Health, Rheumatoid Arthritis)
Regulatory pathways and pre-IND consultation/meetings
Prescription, OTC and medical devices

Cannabis Dirived

Companies developing therapeutics with cannabis derived molecules such as cannabinoids (THC, CBD, CBG etc)
Cannabinoid prescription drugs, Cannabinoid nutraceuticals (organic & synthetic)
Expertise and strategic integration of analytical chemists, API manufacturing and drug formulators

Psychedelics

Experts in all classes of psychedelics
Specialized in psychedelic regulatory pathways
Focused in narcolepsy, treatment resistant depression, major depressive orders, anxiety, opiate addiction & PTSD
Access to US and international research sites

WHY CHOOSE CANNOVATION

Leverage our deep expertise to streamline the success of your next product.

Strategy & Speed to Market

Robust business planning process from research to product development to commercialization

Highly experienced network of technical experts

Rigorous project management

Results orientation

Explore new therapeutic markets

cannovation_solid black background_edite

Turn Key Solutions

Clinical and regulatory roadmaps

New product planning

Launch excellence

Direct partnerships with: Academic Institutions, pharmaceutical companies, DEA researchers, regulatory affairs & material suppliers to cover all your needs